Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran

April 13, 2016 updated by: Hassan Yazdanfar, Islamic Azad University of Mashhad

The Comparison of Dermatophytosis and Other Fungal Infections Between Drug Users and Non Drug Users

The purpose of this study was about survey of prevalence of fungal infections among drug users referring to methadone wards of Hospitals in northeast region of Iran

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

There were two groups with overall members of 1436. Statistically, the investigators have used "Likelihood ratio " and " Exact's Fisher" tests.

Study Type

Observational

Enrollment (Actual)

1436

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Khorasan razavi
      • Mashhad, Khorasan razavi, Iran, Islamic Republic of
        • Islamic Azad University of Mashhad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

people from northeast region of Iran referring to Methadone clinics. there were no limitations of age and sex.

Description

Inclusion Criteria:

  • Suspected fungal lesions

Exclusion Criteria:

  • non use of local or edible anti-fungal drugs and not taking bath within the last 48 hours of testing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Drug Users
Case group that consisted of drug users with fungal infections
It was an observational study and subjects received their routine treatment.
Non-drug Users
Control group that consisted of non drug users with fungal infections
It was an observational study and subjects received their routine treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users
Time Frame: up to two months
up to two months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Hassan Yazdanfar, MD, PhD, assistant professor of mycology and parasitology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

April 1, 2014

Study Registration Dates

First Submitted

January 31, 2016

First Submitted That Met QC Criteria

February 11, 2016

First Posted (Estimate)

February 12, 2016

Study Record Updates

Last Update Posted (Estimate)

May 20, 2016

Last Update Submitted That Met QC Criteria

April 13, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • IslamicAUM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The investigators have not decided about this issue yet

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin and Subcutaneous Tissue Fungal Infections

Clinical Trials on Direct Examination

3
Subscribe